Business Standard

Dr Reddy's names ex-Teva official Erez Israeli as COO, global generics head

New incumbent replaces Abhijit Mukherjee, who retires on March 31 after a 15-year stint at the firm

Dr Reddy's names ex-Teva official Erez Israeli as COO, global generics head
Premium

BS Reporter Hyderabad
Dr Reddy's Laboratories Limited announced a change in the senior leadership team on Thursday, appointed former president and CEO of Enzymotec, Erez Israeli as the chief operating officer and global head of generics and PSAI (pharmaceutical services and active ingredients).
He will replace Abhijit Mukherjee, who is retiring on March 31, 2018 after a 15-year stint in Dr Reddy's.
In a career spanning 25 years, Israeli has held leadership positions that have contributed significantly to the performance of companies he worked for, Dr Reddy's said. Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 29 2018 | 11:14 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com